Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$BURUD $1.40 +28.40% July 25, 2024 (BUSINESS WIRE) @nuburulasers (OTC: BURU), a leading innovator in high-power and high-brightness industrial blue laser technology, is pleased to announce a marketing agreement with NexGenAI Solutions Group #AI https://finance.yahoo.com/news/nuburu-announces-strategic-marketing-partnership-120800770.html
Sxtc $1.15 -> $15 cash per share 700k float
$15.75 cash per share on balance sheet
Per finviz
https://finviz.com/quote.ashx?t=SXTC&p=d
$CATV July 2nd Press Release - Investor Updates: https://catvbt.com/category-v-biotech-inc-announces-exclusive-licensing-of-genetic-networks-intellectual-property-for-cannabis-applications/
Category V Biotech, Inc. (OTC: CATV), formerly known as 4Cable TV International, Inc., is pleased to announce significant progress in our relationship with Genetic Networks, LLC
$SOXL $PBM $PFE $WBD $NVDA
$CYCA Small Cap Analysis: Cytta Corp. (CYCA)
OBLG took a few here plenty of cash, no compliance issues til september, plenty of runs to 30+, think a run is coming
MULN......................................https://stockcharts.com/h-sc/ui?s=MULN&p=D&yr=0&mn=2&dy=12&id=p84071410134
SMALL CAPS ON FIRE! IWM calls is the way to play, target 320 by eoy now 223
$BURU HOT STOCK TO RESEARCH RIGHT NOW! MAJOR NEWS JUST DROPPED!! Nuburu Inc
GTVH bottom intraday forming chart
Bioelectronics (BIEL):
Golden Cross and Blue Skies Breakout Imminent.
The 50 dma is .0001, 200 dma is .0002, yearly high is .0005.
Their Actipatch/RecoveryRx pain relief medical device has international distribution, is highly effective and should be a Standard of Care for every adult and pet on the planet.
They have 5 FDA clearances and a huge patent pending.
Working to expand insurance coverage.
911 Market Maker signal a few days ago.
#1 on the Breakout Boards last Sunday (and #8 on Most Read Boards with over 220,000 reads).
$IVDN: Our R-6 Rated Insultex House Wrap (TM) meets or exceeds new building codes taking effect in 2024 including the requirement for continuous insulation which competitors are failing. A patented evacuated cell design makes it possible. Visit: http://insultexhousewrap.com
CDT just 20 K hear now big news about to be released, get ready for a little inside info....
$OCTO @Eightcoholdings EightCo Achieves Revenues of $100mn in Mobile Phone Business $AGBA $AAPL $META $F $QQQT $RSDN $TSLL $TSLA $SOXL $NTES $SAN $SPY $NVDA $GOOGL $DRMA $FIX $TQQQ https://t.co/ic6Ia4morN
$IFUS #shortsqueeze #cattle #beef #research #drought #CO2 Great article. SGP+ is now being shipped on 48,000 lb flatbed loads to multiple states. This significantly lowers the cost per pound to customer. Also, the bales now have Made in USA with label. https://newsfilecorp.com/company/10534/
GTVH nice update and bottom blunce
$ADIA .015 up She's breaking out HUGE NEWS Nutrition Announces $500,000 Line of Credit and Strategic Expansion Plans
Newsfile Corp.
Newsfile Corp
Winter Park, Florida--(Newsfile Corp. - July 25, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA) is pleased to announce a significant development in the company's strategic growth plan. CEO Larry Powalisz has committed to providing ADIA Nutrition with an up to $500,000 line of credit, demonstrating his unwavering confidence in the company's future and his commitment to its success.
This line of credit is expected to significantly reduce the need for any other outside funding, allowing ADIA Nutrition to focus on its core objectives. The company plans to use these funds to establish a clinic specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for Multiple Sclerosis (MS) patients. This initiative aligns with ADIA Nutrition's mission to revolutionize healthcare through innovative and effective treatments.
Furthermore, the line of credit will also support ADIA Nutrition's expansion and investment plans in its supplement divisions. The company has and will continue to acquire and/or invest in companies that uphold the highest standards of integrity and quality, ensuring that ADIA Nutrition continues to provide premium, organic supplements to its customers.
Larry Powalisz, CEO of ADIA Nutrition Inc., stated, "I was diagnosed with multiple sclerosis three and a half years ago, and at that time, the neurologist told me I would be in a wheelchair within three to five years. The only treatment he offered was Ocrevus, a disease-modifying therapy that had many side effects. I decided to do my own research and went to Mexico to have aHSCT treatment for my MS. I am still walking on my own, no cane, no walker, no wheelchair, and have now been in remission for two and a half years.
Knowing that most MS patients could not afford aHSCT, which typically cost on average $150,000 in the US, and that you have to qualify for the strict small trials being done in the US. I decided to purchase a public company that would create a clinic in the United States to do the treatment, and we will have insurance companies pay for the treatment.
I am thrilled to provide this line of credit to ADIA Nutrition, which will enable us to pursue our ambitious goals and reduce the need for additional external funding. This is a testament to my belief in the company's vision and my way to pay it forward. If it wasn't for aHSCT who knows where I would be today.
Our focus on establishing a clinic for aHSCT treatments for Multiple Sclerosis (MS) and expanding our supplement division reflects our commitment to improving the lives of our customers and patients."
For media inquiries or further information, please contact Larry Powalisz at ceo @101Dahlias-0850.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
https://images.newsfilecorp.com/files/10520/217313_628579b7049859a4_logo.jpg
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/217313
SOURCE Adia Nutrition Inc.
https://api.newsfilecorp.com/newsinfo/217313/130
$VTAK Catheter Precision, Inc. Completes Enrollment of 75 Patients in LockeT-II Study
https://www.accesswire.com/892490/catheter-precision-inc-completes-enrollment-of-75-patients-in-locket-ii-study
$CYCA #OTCQB New Partnership with FIZUAS - Supporting #Drone and Advanced #Streaming Tech Solutions for Rising Demand by Numerous Law Enforcement Agencies; #CyttaCARES Offering a Valuable Solution for the School Safety Crisis: @CyttaCorp https://www.einpresswire.com/article/722643501/cytta-corp-and-fizuas-team-up-to-enhance-drone-and-streaming-tech-for-law-enforcement-cytta-corp-stock-symbol-cyca $DRO $AVAV $AMZN
$ADIA .0015 HUGE NEWS Nutrition Announces $500,000 Line of Credit and Strategic Expansion Plans
Newsfile Corp.
Newsfile Corp
Winter Park, Florida--(Newsfile Corp. - July 25, 2024) - ADIA Nutrition Inc. (OTC Pink: ADIA) is pleased to announce a significant development in the company's strategic growth plan. CEO Larry Powalisz has committed to providing ADIA Nutrition with an up to $500,000 line of credit, demonstrating his unwavering confidence in the company's future and his commitment to its success.
This line of credit is expected to significantly reduce the need for any other outside funding, allowing ADIA Nutrition to focus on its core objectives. The company plans to use these funds to establish a clinic specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) for Multiple Sclerosis (MS) patients. This initiative aligns with ADIA Nutrition's mission to revolutionize healthcare through innovative and effective treatments.
Furthermore, the line of credit will also support ADIA Nutrition's expansion and investment plans in its supplement divisions. The company has and will continue to acquire and/or invest in companies that uphold the highest standards of integrity and quality, ensuring that ADIA Nutrition continues to provide premium, organic supplements to its customers.
Larry Powalisz, CEO of ADIA Nutrition Inc., stated, "I was diagnosed with multiple sclerosis three and a half years ago, and at that time, the neurologist told me I would be in a wheelchair within three to five years. The only treatment he offered was Ocrevus, a disease-modifying therapy that had many side effects. I decided to do my own research and went to Mexico to have aHSCT treatment for my MS. I am still walking on my own, no cane, no walker, no wheelchair, and have now been in remission for two and a half years.
Knowing that most MS patients could not afford aHSCT, which typically cost on average $150,000 in the US, and that you have to qualify for the strict small trials being done in the US. I decided to purchase a public company that would create a clinic in the United States to do the treatment, and we will have insurance companies pay for the treatment.
I am thrilled to provide this line of credit to ADIA Nutrition, which will enable us to pursue our ambitious goals and reduce the need for additional external funding. This is a testament to my belief in the company's vision and my way to pay it forward. If it wasn't for aHSCT who knows where I would be today.
Our focus on establishing a clinic for aHSCT treatments for Multiple Sclerosis (MS) and expanding our supplement division reflects our commitment to improving the lives of our customers and patients."
For media inquiries or further information, please contact Larry Powalisz at ceo @101Dahlias-0850.
About ADIA Nutrition Inc.:
Adia Nutrition Inc. is a publicly traded company (OTC Pink: ADIA) dedicated to revolutionizing healthcare and supplementation. With a focus on innovation and quality, the company has established two key divisions: a supplement division providing premium, organic supplements, and a medical division specializing in Autologous Hematopoietic Stem Cell Transplantation (aHSCT) treatments for Multiple Sclerosis (MS). Through these divisions, Adia Nutrition Inc. is committed to empowering individuals to live their best lives by addressing both nutritional needs and groundbreaking medical treatments.
Website: www.adianutrition.com
Twitter (X): @ADIA_Nutrition
Safe Harbor: This Press Release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a few uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission and OTC Markets, Inc. OTC Disclosure and News Service. The company undertakes no obligation to publicly update or revise any forward-looking statements, because of new information, future events or otherwise.
https://images.newsfilecorp.com/files/10520/217313_628579b7049859a4_logo.jpg
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/217313
SOURCE Adia Nutrition Inc.
https://api.newsfilecorp.com/newsinfo/217313/130
$MGRX
$MGRX march to its FAIR Market Value has begun ⬇️ me thinks pic.twitter.com/LB0mTg7ZeX
— KIR (@KeepRealistic) July 25, 2024
$BURUD #breakingnews NUBURU Announces Strategic Marketing Partnership with NexGenAI Solutions Group https://finance.yahoo.com/news/nuburu-announces-strategic-marketing-partnership-120800770.html?soc_src=social-sh&soc_trk=tw&tsrc=twtr via @YahooFinance @nuburulasers
$NHYF onward and upward $$
Globe Small Cap Research Report out on Golden Triangle Ventures Inc. ( OTC Pink: $GTVH ) US $0.003 Per Share Market Cap: $3.8M 52-week range: $0.002 - $0.007
https://www.dropbox.com/scl/fi/katajdp8w2ugp02zv6lmi/GTVH-Golden-Triangle-Ventures-Report-July-2024.pdf?rlkey=sfmcahj6b4g5qe5ayvndxyw1s&st=jwysk07d&dl=0
🚨 #BreakingNews: $AMPG AmpliTech Group's Division, AmpliTech Inc, Unveils Quantum Computing Cryogenic Power Supplies https://finance.yahoo.com/news/amplitech-groups-division-amplitech-inc-123000168.html
$AIMD #NASDAQ Exciting news! 🎙️ Check out the latest Water Tower Hour Podcast featuring Ainos | AI + Nose's Jack Lu , Jack dives into the innovative #AI Nose platform, shedding light on how Ainos Flora could transform the STI test market. 🌐 Don't miss out on exploring the potential of AI Nose beyond #healthcare! 🔍
Listen on Apple #Podcasts #Apple: https://podcasts.apple.com/us/podcast/the-water-tower-hour/id1693448305
#Spotify: https://open.spotify.com/show/65HhA2UPZVDW55kA3sCkXh
🍏
Stream on Spotify: 🎧
#Podcast #AIMD #AINose #MedTech #WTR #WaterTowerResearch @charles
$POAI terrific...Now in nano-float clone play $AYRO @ .80:.. Has 5M total shares. 15% short. Has $7.38 a share cash.
The mob WILL run it....Too easy. A sitting duck. Maybe the best stock lotto play right now.
Link:
ayro.com/
Chatbots in Investor Relations: A New Era of Efficient Communication and How 1606 Corp $CBDW is Leading the Way on the OTC https://cbdw.ai/chatbots-in-investor-relations-a-new-era-of-efficient-communication-and-how-1606-corp-cbdw-is-leading-the-way-on-the-otc/
$IVDN on Seekingalpha.com- Innovative Designs Vendor Growth https://seekingalpha.com/pr/19683617-innovative-designs-vendor-growth?source=tweet @SeekingAlpha
$CATV Great news! Exclusive Licensing Of Genetic Networks’ Intellectual Property For Cannabis Applications https://t.co/cAoAsiTYGk
#ShareStructure #Lotto #pennystock @OTCMarkets
$AI $PANW $PLTR $SNOW $NVDA $MSFT $AMZN $PATH $CDNS
ADIA nice news ADIA Nutrition Announces $500,000 Line of Credit and Strategic Expansion Plans https://www.otcmarkets.com/stock/ADIA/news/story?e&id=2927969
GRI took a few down here bottoming out
bottom play..................................https://stockcharts.com/h-sc/ui?s=muln&p=D&yr=0&mn=2&dy=12&id=p84071410134
$CBDW .0333 +23.33% Another green open for #AI Stocks $AAPL $219.85 $NVDA $113.91 #Bullish www.cbdw.ai
Followers
|
9998
|
Posters
|
|
Posts (Today)
|
11
|
Posts (Total)
|
4975172
|
Created
|
01/10/04
|
Type
|
Free
|
Moderator i_like_bb_stock | |||
Assistants koolmc MOMO vantillian Rainer StockRocket |
Goal: TO PROVIDE A FORUM FOR BOTH EXPERIENCED AND NOVICE TRADERS TO SHARE THEIR OPINIONS ON STOCKS TRADED ON THE BULLETIN BOARD OR PINK SHEET MARKETS, AS WELL AS THE BIG BOARDS. FUNDAMENTALS, NEWS, RUMORS ARE WELCOME, BUT FOR THE MOST PART, THIS BOARD WILL BE TO SHARE TECHNICAL ANALYSIS. TIMING IS EVERYTHING WHEN BUYING OR SELLING A STOCK, AND TECHNICAL ANALYSIS CAN OFTEN DETERMINE THE APPROPRIATE ACTION TO TAKE. ALL TECHNICAL INDICATORS ARE WELCOME. FOR NOVICE TRADERS, QUESTIONS ARE WELCOMED, AND SOMEONE WILL TRY AND HELP YOU WITH THE ANSWER. I WAS ONCE A NOVICE TRADER, AND KNOW THAT GUIDANCE WOULD HAVE HELPED ME SEVERAL YEARS AGO, SO I WOULD LIKE TO HELP YOU AS MUCH AS POSSIBLE. -- i_like_bb_stock |
Rules:1) Spam of any kind will not be tolerated2) There will be times when posters are not in agreement, that is healthy, but please no personal attacks. 3) No specific price preference for the board but these are mostly OTC stocks. 4) Volume is the blood in a stock's veins, so I typically prefer stocks with historical volume, otherwise there is little liquidity for selling the stock if need be. 5) Posting charts and annotations if you have a service that provides it are highly welcome since this provides support for your buy/sell/hold signal. 6) As always, do your due diligence, and remember that there is high risk in these types of stocks. Never trade with money that you cannot afford to loose. 7) If the post is Off Topic, please post with OT prefacing the post. |
Some relevent info:1) For SEC filings I use www.otcmarkets.com.2) For daily charts I use www.stockcharts.com. There is a free service which is time delayed, and then different levels of paid service. 3) To post a chart from stockcharts.com, right click on the chart, click "Copy Image URL". Within the post, right click and click Paste. Remove "http://" then place the chart URL between these tags [*chart]URL[*/chart] (remove the asterisks) 4) For level II, there are various services, IHUB has its own services, individual brokers as well, I use TDAmeritrade, which offers free level II if you have an account. 5) I use equityfeed.com which is critical for any otc trader. It has level II as well, real time news, scanning, and a plethora of things that are needed as a trader. There are various price points based on your needs. 6) For a great listing of stock terms or investor information, use www.investopedia.com or www.investorwords.com. 7) For more info on chart formations, see http://www.chartpatterns.com and http://thepatternsite.com. 8) To find splits, symbol changes etc., use http://otce.finra.org/DailyList 9) Remember also to sell into strength and buy into weakness. When possible, try not to sell at the bid. When a stock is strong, you can usually at least get filled somewhere between the bid/ask, selling at the bid will often hurt the stock, since the market makers make take the bid down further afterwards. 10) For info on stockcharts.com, see the Stockcharts board on the Hub: http://www.investorshub.com/boards/board.asp?board_id=1277 |
Posts Today
|
11
|
Posts (Total)
|
4975172
|
Posters
|
|
Moderator
|
|
Assistants
|
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |